Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial

Ildiko Lingvay, Stewart Harris, Elmar Jaeckel, Keval Chandarana, Mattis F. Ranthe, Esteban Jódar

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences